Dr. Reddy’s Lab get CRL from USFDA for NuvaRing, Copaxone

16 Aug 2019 Evaluate

Dr. Reddy's Laboratories has received complete response letter (CRL) from the US Food and Drug Administration (USFDA) for its versions of NuvaRing and Copaxone. NuvaRing is a birth control device and Copaxone (glatiramer acetate injection) is a multi-billion dollar drug and a prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

6239.60 22.45 (0.36%)
26-Apr-2024 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1529.90
Dr. Reddys Lab 6239.60
Cipla 1414.75
Zydus Lifesciences 951.00
Lupin 1585.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.